FDA Approval Sends Shares on a Tear
25 Settembre 2023 - 4:30PM
AllPennyStocks.com
The morning opened up on a high note for this dually-listed
company as it announced U.S. Food and Drug Administration (FDA)
approval of its Metronidazole Oral Suspension 500mg/5mL ( ATI-1501
)....
To read the full story on AllPennyStocks.com, click
here.
Grafico Azioni Appili Therapeutics (TSX:APLI)
Storico
Da Ago 2024 a Set 2024
Grafico Azioni Appili Therapeutics (TSX:APLI)
Storico
Da Set 2023 a Set 2024